Filana Therapeutics, Inc. Operating Lease Cost
Filana Therapeutics, Inc. (FLNA) reported Operating Lease Cost of $0 for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2024-05-10
- Filana Therapeutics, Inc. operating lease, cost for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- Filana Therapeutics, Inc. operating lease, cost for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Filana Therapeutics, Inc. operating lease, cost for the quarter ending 2023-03-31 was $24.00K.
- Filana Therapeutics, Inc. operating lease, cost for the quarter ending 2022-09-30 was $41.00K.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 9 month |
|---|---|---|
| 2024-03-31 | $0.00 10-Q · filed 2024-05-10 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-07 | $24.00K 10-Q · filed 2023-11-07 |
| 2023-03-31 | $24.00K 10-Q · filed 2024-05-10 | |
| 2022-09-30 | $41.00K 10-Q · filed 2023-11-07 | $123.00K 10-Q · filed 2023-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |